Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

The HonorHealth Research Institute says it used a new immunotherapy to respond to a patient’s solid tumors. According to the ...

Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Over the past few years, interest in using AI to design drugs and optimize clinical trials has driven a surge in research and investment ... hinder scientists from moving beyond the mechanics of ...